Ratings by H.C. Wainwright (Yi Chen)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2024 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2024 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2024 | OKYO Pharma Ltd. | OKYO | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2024 | First Wave BioPharma, Inc. | FWBI | New Coverage | Neutral (N/A) |
4.42 (3.02) |
-31.67% | Details | |
| 3/25/2024 | Genprex | GNPX | New Coverage | Buy (N/A) |
3.06 (2.21) |
-27.78% | Details | |
| 3/22/2024 | Barinthus Biotherapeutics | BRNS | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | Aslan Pharma | ASLN | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | Regenxbio Inc. | RGNX | New Coverage | Buy (N/A) |
22.75 (16.04) |
-29.49% | Details | |
| 3/11/2024 | Alimera Sciences | ALIM | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2024 | Mainz Biomed B.V. | MYNZ | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Bausch & Lomb Corp. | BLCO | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Greenwich LifeSciences | GLSI | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2024 | AngioDynamics | ANGO | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | OKYO Pharma Ltd. | OKYO | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2024 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2024 | Kiora Pharmaceuticals | KPRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2024 | OKYO Pharma Ltd. | OKYO | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2024 | AngioDynamics | ANGO | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2023 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2023 | Mainz Biomed B.V. | MYNZ | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2023 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | ProPhase Labs, Inc | PRPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Kiora Pharmaceuticals | KPRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | OKYO Pharma Ltd. | OKYO | New Coverage | Buy (N/A) |
1.60 (1.41) |
-11.88% | Details | |
| 10/9/2023 | Bausch & Lomb Corp. | BLCO | Maintain | Buy (N/A) |
|
Details | ||
| 10/5/2023 | AngioDynamics | ANGO | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2023 | Mainz Biomed B.V. | MYNZ | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2023 | AngioDynamics | ANGO | New Coverage | Buy (N/A) |
7.02 (5.87) |
-16.38% | Details | |
| 8/21/2023 | Nemaura Medical Inc | NMRD | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2023 | Mainz Biomed B.V. | MYNZ | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | Kiora Pharmaceuticals | KPRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | OpGen | OPGN | Downgrade | Neutral (Buy) |
0.26 (0.56) |
115.38% | Details | |
| 7/14/2023 | First Wave BioPharma, Inc. | FWBI | Downgrade | Neutral (Buy) |
0.91 (3.02) |
231.87% | Details | |
| 7/3/2023 | LifeMD Inc | LFMD | New Coverage | Buy (N/A) |
4.35 (11.16) |
156.55% | Details | |
| 6/16/2023 | Motus GI Holdings | MOTS | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2023 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Check-Cap | CHEK | Downgrade | Neutral (Buy) |
1.95 (2.22) |
13.85% | Details | |
| 6/5/2023 | Belite Bio, Inc, ADR | BLTE | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2023 | Alimera Sciences | ALIM | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2023 | Bausch & Lomb Corp. | BLCO | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2023 | Centogene NV | CNTG | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Veru, Inc. | VERU | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Kiora Pharmaceuticals | KPRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | ProPhase Labs, Inc | PRPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2023 | Bausch & Lomb Corp. | BLCO | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2023 | Aslan Pharma | ASLN | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Mainz Biomed B.V. | MYNZ | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2023 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2023 | Greenwich LifeSciences | GLSI | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2023 | Veru, Inc. | VERU | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2023 | Check-Cap | CHEK | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2023 | First Wave BioPharma, Inc. | FWBI | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2023 | HTG Molecular Diagnostics | HTGM | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2023 | Renalytix AI Plc. | RNLX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2023 | Kiora Pharmaceuticals | KPRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2023 | Vaccitech | VACC | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2023 | Anixa Biosciences | ANIX | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Aslan Pharma | ASLN | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2023 | Zynex Inc. | ZYXI | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2023 | Nemaura Medical Inc | NMRD | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2023 | Aslan Pharma | ASLN | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Bausch & Lomb Corp. | BLCO | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2023 | Veru, Inc. | VERU | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2022 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2022 | Veru, Inc. | VERU | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2022 | Renalytix AI Plc. | RNLX | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2022 | First Wave BioPharma, Inc. | FWBI | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | Centogene NV | CNTG | New Coverage | Buy (N/A) |
0.75 (0.46) |
-38.67% | Details | |
| 11/11/2022 | ProPhase Labs, Inc | PRPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Clearside Biomedical | CLSD | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Veru, Inc. | VERU | Maintain | Buy (Buy) |
|
Details | ||
| 11/3/2022 | Bausch & Lomb Corp. | BLCO | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Renalytix AI Plc. | RNLX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | First Wave BioPharma, Inc. | FWBI | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Bausch & Lomb Corp. | BLCO | New Coverage | Buy (N/A) |
17.17 (14.90) |
-13.22% | Details | |
| 8/19/2022 | Nemaura Medical Inc | NMRD | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Motus GI Holdings | MOTS | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | HTG Molecular Diagnostics | HTGM | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2022 | Belite Bio, Inc, ADR | BLTE | New Coverage | Buy (N/A) |
33.60 (37.27) |
10.92% | Details | |
| 7/11/2022 | Kiora Pharmaceuticals | KPRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2022 | Meridian Biosciences | VIVO | Downgrade | Neutral (Buy) |
33.27 (33.97) |
2.1% | Details | |
| 7/7/2022 | Veru, Inc. | VERU | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2022 | Renalytix AI Plc. | RNLX | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2022 | Mainz Biomed B.V. | MYNZ | New Coverage | Buy (N/A) |
8.98 (0.90) |
-89.98% | Details | |
| 5/24/2022 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2022 | Bio-Path Holdings | BPTH | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | Nemaura Medical Inc | NMRD | New Coverage | Buy (N/A) |
4.08 (0.11) |
-97.3% | Details | |
| 3/1/2022 | DENTSPLY SIRONA | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 2/25/2022 | Zynex Inc. | ZYXI | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2022 | Meridian Biosciences | VIVO | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Renalytix AI Plc. | RNLX | New Coverage | Buy (N/A) |
15.38 (0.64) |
-95.84% | Details | |
| 12/28/2021 | Zynex Inc. | ZYXI | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2021 | Ortho Clinical Diagnostics | OCDX | Downgrade | Neutral (Buy) |
21.16 (17.63) |
-16.68% | Details | |
| 12/20/2021 | ProPhase Labs, Inc | PRPH | New Coverage | Buy (N/A) |
7.29 (5.06) |
-30.59% | Details | |
| 11/17/2021 | Interpace Diagnostics Group Inc | IDXG | Downgrade | Neutral (Buy) |
7.82 (1.55) |
-80.18% | Details | |
| 11/16/2021 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Meridian Biosciences | VIVO | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2021 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 9/1/2021 | Greenwich LifeSciences | GLSI | New Coverage | Buy (N/A) |
40.02 (12.62) |
-68.47% | Details | |
| 8/13/2021 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2021 | Ocular Therapeutix | OCUL | Upgrade | Buy (Neutral) |
10.73 (4.65) |
-56.66% | Details | |
| 8/9/2021 | Meridian Biosciences | VIVO | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | DENTSPLY SIRONA | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 7/29/2021 | Clearside Biomedical | CLSD | New Coverage | Buy (N/A) |
5.12 (1.34) |
-73.83% | Details | |
| 5/24/2021 | Interpace Diagnostics Group Inc | IDXG | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2021 | Vaccitech | VACC | New Coverage | Buy (N/A) |
14.58 (5.00) |
-65.71% | Details | |
| 5/10/2021 | Meridian Biosciences | VIVO | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2021 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2021 | Alimera Sciences | ALIM | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2021 | Anixa Biosciences | ANIX | New Coverage | Buy (N/A) |
4.50 (3.18) |
-29.33% | Details | |
| 4/1/2021 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2021 | Aslan Pharma | ASLN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | DENTSPLY SIRONA | XRAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2021 | CareDx, Inc | CDNA | Downgrade | Neutral (Buy) |
79.26 (7.98) |
-89.93% | Details | |
| 2/22/2021 | Ortho Clinical Diagnostics | OCDX | New Coverage | Buy (N/A) |
16.79 (17.63) |
5% | Details | |
| 2/10/2021 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2021 | DENTSPLY SIRONA | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 12/28/2020 | Ocular Therapeutix | OCUL | Downgrade | Neutral (Buy) |
22.08 (4.65) |
-78.94% | Details | |
| 12/22/2020 | Eyegate Pharmaceuticals | EYEG | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2020 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2020 | Zynex Inc. | ZYXI | Upgrade | Buy (Neutral) |
15.49 (11.23) |
-27.5% | Details | |
| 8/17/2020 | Bio-Path Holdings | BPTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2020 | Aerpio Pharmaceuticals | ARPO | Maintain | Neutral (N/A) |
|
Details | ||
| 7/27/2020 | Meridian Biosciences | VIVO | New Coverage | Buy (N/A) |
23.15 (33.97) |
46.74% | Details | |
| 7/20/2020 | Applied DNA Sciences | APDN | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2020 | CYDY | Downgrade | Neutral (Buy) |
6.08 (0.15) |
-97.53% | Details | ||
| 7/2/2020 | Applied DNA Sciences | APDN | New Coverage | Buy (N/A) |
7.75 (0.24) |
-96.9% | Details | |
| 6/25/2020 | Aerpio Pharmaceuticals | ARPO | Maintain | Neutral (N/A) |
|
Details | ||
| 6/15/2020 | DENTSPLY International | XRAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2020 | Zynex Inc. | ZYXI | Downgrade | Neutral (Buy) |
20.26 (11.23) |
-44.57% | Details | |
| 5/18/2020 | Bio-Path Holdings | BPTH | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2020 | HTG Molecular Diagnostics | HTGM | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2020 | Zynex Inc. | ZYXI | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2020 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2020 | Interpace Diagnostics Group Inc | IDXG | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2020 | CytoDyn | CYDY | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2020 | Stealth BioTherapeutics | MITO | Upgrade | Buy (Neutral) |
1.23 (0.32) |
-73.98% | Details | |
| 4/1/2020 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2020 | HTG Molecular Diagnostics | HTGM | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | DENTSPLY International | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2020 | Ocular Therapeutix | OCUL | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2019 | Stealth BioTherapeutics | MITO | Downgrade | Neutral (Buy) |
4.75 (1.23) |
-74.11% | Details | |
| 12/10/2019 | Aslan Pharma | ASLN | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2019 | Bio-Path Holdings | BPTH | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Alimera Sciences | ALIM | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | DENTSPLY International | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2019 | Alimera Sciences | ALIM | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2019 | Stealth BioTherapeutics | MITO | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2019 | CytoDyn Inc. | CYDY | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | T2 Biosystems, Inc | TTOO | Downgrade | Neutral (Buy) |
1.44 (2.76) |
91.67% | Details | |
| 7/29/2019 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Bio-Path Holdings | BPTH | New Coverage | Buy (N/A) |
12.89 (2.49) |
-80.68% | Details |
